NO20033653L - Ny filmcoating - Google Patents

Ny filmcoating

Info

Publication number: NO20033653L
Authority: NO; Norway
Prior art keywords: film coating; new film; pharmaceutical formulations; modified release; film
Prior art date: 2001-12-19

Application number

NO20033653A

Other languages

English (en)

Other versions

NO320358B1 (no

NO20033653D0 (no

Inventor

Lars Johan Pontus D Hjaertstam

Jan-Erik Loefroth

Staffan Schantz

Anders Welin

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-19

Filing date

2003-08-18

Publication date

2003-10-10

2001-12-19 Priority claimed from SE0104328A external-priority patent/SE0104328D0/xx

2001-12-19 Priority claimed from SE0104327A external-priority patent/SE0104327D0/xx

2003-08-18 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-08-18 Publication of NO20033653D0 publication Critical patent/NO20033653D0/no

2003-10-10 Publication of NO20033653L publication Critical patent/NO20033653L/no

2005-11-28 Publication of NO320358B1 publication Critical patent/NO320358B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Medicinal Preparation (AREA)
Paints Or Removers (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Compositions Of Macromolecular Compounds (AREA)
Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Piezo-Electric Transducers For Audible Bands (AREA)
Surface Treatment Of Glass Fibres Or Filaments (AREA)

NO20033653A 2001-12-19 2003-08-18 Filmcoatingsammensetning, filmbelegg og modifisert frigivelsesfarmasoytisk formulering, samt fremgangsmater for fremstilling derav NO320358B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE0104328A SE0104328D0 (sv)	2001-12-19	2001-12-19	New film coating
SE0104327A SE0104327D0 (sv)	2001-12-19	2001-12-19	New film coating
PCT/GB2002/005739 WO2003051340A1 (en)	2001-12-19	2002-12-18	New film coating

Publications (3)

Publication Number	Publication Date
NO20033653D0 NO20033653D0 (no)	2003-08-18
NO20033653L true NO20033653L (no)	2003-10-10
NO320358B1 NO320358B1 (no)	2005-11-28

Family

ID=26655630

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20033653A NO320358B1 (no)	2001-12-19	2003-08-18	Filmcoatingsammensetning, filmbelegg og modifisert frigivelsesfarmasoytisk formulering, samt fremgangsmater for fremstilling derav

Country Status (25)

Country	Link
US (2)	US6827947B2 (no)
EP (2)	EP1477163A1 (no)
JP (1)	JP2005514386A (no)
KR (1)	KR20040065989A (no)
CN (1)	CN100341491C (no)
AT (1)	ATE287259T1 (no)
AU (2)	AU2002361447B2 (no)
BR (1)	BR0206441A (no)
CA (1)	CA2435729C (no)
CZ (1)	CZ20031970A3 (no)
DE (2)	DE20220902U1 (no)
DK (1)	DK1355633T3 (no)
ES (1)	ES2233876T3 (no)
HU (1)	HUP0303886A3 (no)
IL (1)	IL156998A0 (no)
IS (1)	IS6863A (no)
MX (1)	MXPA03007156A (no)
NO (1)	NO320358B1 (no)
NZ (1)	NZ526926A (no)
PL (1)	PL362378A1 (no)
PT (1)	PT1355633E (no)
RU (1)	RU2323717C2 (no)
SI (1)	SI1355633T1 (no)
SK (1)	SK9132003A3 (no)
WO (1)	WO2003051340A1 (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0100200D0 (sv) *	2001-01-24	2001-01-24	Astrazeneca Ab	New film coating
PT1355633E (pt) *	2001-12-19	2005-05-31	Astrazeneca Ab	Nova pelicula contendo um copolimero de acrilato de etilo/metacrilato de metilo e poli(acetato de vinilo)
ES2627842T3 (es)	2002-02-21	2017-07-31	Valeant Pharmaceuticals Luxembourg S.À.R.L.	Formas de dosificación de liberación controlada
SE0201110D0 (sv) *	2002-04-12	2002-04-12	Astrazeneca Ab	New film coating
SE0202353D0 (sv) *	2002-08-01	2002-08-01	Astrazeneca Ab	New film coating
US7080545B2 (en) *	2002-10-17	2006-07-25	Advanced Technology Materials, Inc.	Apparatus and process for sensing fluoro species in semiconductor processing systems
WO2005041934A2 (de) *	2003-10-31	2005-05-12	Hexal Ag	Pharmazeutische wirkstoffhaltige formulierung mit überzug
WO2005084636A2 (en) *	2004-02-27	2005-09-15	Ranbaxy Laboratories Limited	A process for the preparation of controlled-release pharmaceutical composition of metoprolol
JP2005306778A (ja) *	2004-04-21	2005-11-04	Basf Ag	徐放性製剤及びその製造方法
US7838031B2 (en) *	2004-05-21	2010-11-23	Lawrence Solomon	Method of administering a partial dose using a segmented pharmaceutical tablet
DE102004035936A1 (de) *	2004-07-23	2006-03-16	Röhm GmbH & Co. KG	Mehrschichtige Arzneiform
RU2435573C2 (ru) *	2005-07-28	2011-12-10	ШИР ЭлЭлСи	Фармацевтические составы на основе гуанфацина, подходящие для ежедневного введения в виде единичной дозированной формы
JP5259413B2 (ja) *	2005-11-18	2013-08-07	エーシーシーユー−ブレイクテクノロジーズ，インク．	セグメント化した薬の剤形
DE102005060393A1 (de)	2005-12-16	2007-06-21	Add Advanced Drug Delivery Technologies Ltd.	Orales Präparat mit kontrollierter Freisetzung
US20080118570A1 (en) *	2006-11-20	2008-05-22	Zhi Liu	Polymer coated drug-ion exchange resins and methods
US20100303920A1 (en) *	2009-05-27	2010-12-02	Johan Hjartstam	Aqueous Film Coating Composition / 841
US9284307B2 (en)	2009-08-05	2016-03-15	Idenix Pharmaceuticals Llc	Macrocyclic serine protease inhibitors
WO2011056764A1 (en)	2009-11-05	2011-05-12	Ambit Biosciences Corp.	Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
JP2013514982A (ja)	2009-12-18	2013-05-02	イデニクプハルマセウティカルス，インコーポレイテッド	５，５−縮合アリーレン又はヘテロアリーレンｃ型肝炎ウイルス阻害剤
IL210279A0 (en)	2009-12-25	2011-03-31	Dexcel Pharma Technologies Ltd	Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients
WO2011094890A1 (en)	2010-02-02	2011-08-11	Argusina Inc.	Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
WO2011112689A2 (en)	2010-03-11	2011-09-15	Ambit Biosciences Corp.	Saltz of an indazolylpyrrolotriazine
US8703943B2 (en)	2010-09-01	2014-04-22	Ambit Biosciences Corporation	Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
AU2011296046B2 (en)	2010-09-01	2015-05-14	Ambit Biosciences Corporation	Hydrobromide salts of a pyrazolylaminoquinazoline
EP2648676A4 (en)	2010-12-06	2016-05-04	Follica Inc	METHODS FOR TREATING CALVITIA AND PROMOTING HAIR GROWTH
WO2012080050A1 (en)	2010-12-14	2012-06-21	F. Hoffmann-La Roche Ag	Solid forms of a phenoxybenzenesulfonyl compound
EP2670396A1 (en)	2011-01-31	2013-12-11	Celgene Corporation	Pharmaceutical compositions of cytidine analogs and methods of use thereof
AR085352A1 (es)	2011-02-10	2013-09-25	Idenix Pharmaceuticals Inc	Inhibidores macrociclicos de serina proteasa, sus composiciones farmaceuticas y su uso para tratar infecciones por hcv
US20120252721A1 (en)	2011-03-31	2012-10-04	Idenix Pharmaceuticals, Inc.	Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
CN103501768B (zh) *	2011-06-17	2016-11-09	赢创罗姆有限公司	具有抗乙醇影响抗性的抗胃酸的药物或营养组合物
US9844511B2 (en) *	2011-06-17	2017-12-19	Evonik Roehm Gmbh	Coating composition suitable for pharmaceutical or nutraceutical dosage forms
HK1207072A1 (en)	2012-03-16	2016-01-22	埃克希金医药品有限公司	3,5-diaminopyrazole kinase inhibitors
EP2956124A1 (en)	2013-02-13	2015-12-23	Evonik Röhm GmbH	Multiparticulate pharmaceutical composition comprising a multitude of two kinds of pellets
NZ631142A (en)	2013-09-18	2016-03-31	Axikin Pharmaceuticals Inc	Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
US20160229866A1 (en)	2013-09-20	2016-08-11	Idenix Pharmaceuticals Inc.	Hepatitis c virus inhibitors
JP5846185B2 (ja)	2013-11-21	2016-01-20	大日本印刷株式会社	貫通電極基板及び貫通電極基板を用いた半導体装置
WO2015134560A1 (en)	2014-03-05	2015-09-11	Idenix Pharmaceuticals, Inc.	Solid forms of a flaviviridae virus inhibitor compound and salts thereof
RU2021101430A (ru)	2014-03-20	2021-03-16	Капелла Терапьютикс, Инк.	Производные бензимидазола как ингибиторы тирозинкиназ erbb для лечения рака
KR102409739B1 (ko)	2014-03-20	2022-06-17	카펠라 테라퓨틱스, 인크.	암 치료용의 ｅｒｂｂ 티로신 키나제 억제제로서의 벤즈이미다졸 유도체
BR112017000468A2 (pt) *	2014-07-09	2017-11-07	Sun Pharmaceutical Ind Ltd	forma de dosagem de cápsula de liberação prolongada
WO2016042565A1 (en) *	2014-09-16	2016-03-24	Suresh Pareek	Extended release 'formulation of metoprolol
EA032473B1 (ru)	2014-12-23	2019-05-31	Аксикин Фармасьютикалз, Инк.	3,5-диаминопиразоловые ингибиторы киназы
MX2019000213A (es) *	2016-06-30	2019-05-13	Beckman Coulter Inc	Sustratos quimiluminiscentes.
WO2019183470A2 (en)	2018-03-22	2019-09-26	Incarda Therapeutics, Inc.	A novel method to slow ventricular rate
US12303604B1 (en)	2024-10-16	2025-05-20	Currax Pharmaceuticals Llc	Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB878234A (en)	1958-12-18	1961-09-27	Roehm & Haas Gmbh	Pharmaceutical coating compositions
DE1228757B (de) *	1962-06-28	1966-11-17	Haessle Ab	Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
US3341338A (en) *	1965-05-28	1967-09-12	Union Carbide Corp	Polysiloxane polish formulations
DE2031871C3 (de) *	1970-06-27	1974-06-27	Roehm Gmbh, 6100 Darmstadt	Überzugsmasse für Arzneiformen
US4330338A (en) *	1978-10-02	1982-05-18	Purdue Research Foundation	Pharmaceutical coating composition, and preparation and dosages so coated
US4916171A (en) *	1984-07-25	1990-04-10	Rohm And Haas Company	Polymers comprising alkali-insoluble core/alkali-soluble shell and copositions thereof
SE8404467D0 (sv)	1984-09-06	1984-09-06	Ferrosan Ab	Controlled-release medical preparations
SE455836B (sv) *	1985-10-11	1988-08-15	Haessle Ab	Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
SE450087B (sv) *	1985-10-11	1987-06-09	Haessle Ab	Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
US5246714A (en) *	1985-10-11	1993-09-21	Aktiebolaget Hassle	Drug preparation
US4975283A (en) *	1985-12-12	1990-12-04	Bristol-Myers Squibb Company	Stabilized enteric coated aspirin granules and process for preparation
US4800087A (en) *	1986-11-24	1989-01-24	Mehta Atul M	Taste-masked pharmaceutical compositions
US4874613A (en) *	1987-03-06	1989-10-17	Baker Cummins Pharmaceuticals, Inc.	Taste concealing pharmaceutical dosage unit
US4871546A (en) *	1987-06-29	1989-10-03	Sandoz Pharm. Corp.	Gastrointestinal protective coating formulations
JP2782691B2 (ja)	1987-09-29	1998-08-06	ワーナー−ランバート・コンパニー	腸溶製剤の安定化
US5292522A (en) *	1989-06-20	1994-03-08	Rohm Gmbh	Aqueous film coating agent for solid medicaments
FR2655266B1 (fr)	1989-12-05	1992-04-03	Smith Kline French Lab	Compositions pharmaceutiques a base de cimetidine.
GB9200607D0 (en) *	1992-01-13	1992-03-11	Ethical Pharma Ltd	Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US5376384A (en) *	1992-12-23	1994-12-27	Kinaform Technology, Inc.	Delayed, sustained-release pharmaceutical preparation
ATE195252T1 (de) *	1993-04-23	2000-08-15	Novartis Erfind Verwalt Gmbh	Wirkstoffabgabevorrichtung mit gesteuerter freigabe
CA2117546A1 (en) *	1993-08-27	1995-02-28	Takateru Muraoka	Medical adhesive sheet
DE4444051A1 (de) *	1994-12-10	1996-06-13	Rhone Poulenc Rorer Gmbh	Pharmazeutische, oral anwendbare Zubereitung
US5871776A (en) *	1995-01-31	1999-02-16	Mehta; Atul M.	Controlled-release nifedipine
DE19615812A1 (de) *	1996-04-20	1997-10-23	Boehringer Mannheim Gmbh	Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation
US6046177A (en) *	1997-05-05	2000-04-04	Cydex, Inc.	Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
US6627223B2 (en) *	2000-02-11	2003-09-30	Eurand Pharmaceuticals Ltd.	Timed pulsatile drug delivery systems
SE0100200D0 (sv)	2001-01-24	2001-01-24	Astrazeneca Ab	New film coating
PT1355633E (pt) *	2001-12-19	2005-05-31	Astrazeneca Ab	Nova pelicula contendo um copolimero de acrilato de etilo/metacrilato de metilo e poli(acetato de vinilo)
US20030175342A1 (en) *	2002-03-14	2003-09-18	Karl Kolter	Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
SE0201110D0 (sv) *	2002-04-12	2002-04-12	Astrazeneca Ab	New film coating
SE0202353D0 (sv) *	2002-08-01	2002-08-01	Astrazeneca Ab	New film coating

2002
- 2002-12-18 PT PT02796920T patent/PT1355633E/pt unknown
- 2002-12-18 WO PCT/GB2002/005739 patent/WO2003051340A1/en not_active Ceased
- 2002-12-18 DE DE20220902U patent/DE20220902U1/de not_active Expired - Lifetime
- 2002-12-18 US US10/450,794 patent/US6827947B2/en not_active Expired - Fee Related
- 2002-12-18 NZ NZ526926A patent/NZ526926A/en unknown
- 2002-12-18 AT AT02796920T patent/ATE287259T1/de not_active IP Right Cessation
- 2002-12-18 IL IL15699802A patent/IL156998A0/xx unknown
- 2002-12-18 DE DE60202662T patent/DE60202662T2/de not_active Expired - Lifetime
- 2002-12-18 JP JP2003552273A patent/JP2005514386A/ja not_active Withdrawn
- 2002-12-18 KR KR10-2003-7010812A patent/KR20040065989A/ko not_active Ceased
- 2002-12-18 EP EP04019487A patent/EP1477163A1/en not_active Withdrawn
- 2002-12-18 SK SK913-2003A patent/SK9132003A3/sk unknown
- 2002-12-18 ES ES02796920T patent/ES2233876T3/es not_active Expired - Lifetime
- 2002-12-18 PL PL36237802A patent/PL362378A1/xx not_active Application Discontinuation
- 2002-12-18 AU AU2002361447A patent/AU2002361447B2/en not_active Ceased
- 2002-12-18 DK DK02796920T patent/DK1355633T3/da active
- 2002-12-18 HU HU0303886A patent/HUP0303886A3/hu unknown
- 2002-12-18 EP EP02796920A patent/EP1355633B1/en not_active Expired - Lifetime
- 2002-12-18 SI SI200230088T patent/SI1355633T1/xx unknown
- 2002-12-18 BR BR0206441-3A patent/BR0206441A/pt not_active IP Right Cessation
- 2002-12-18 CA CA002435729A patent/CA2435729C/en not_active Expired - Fee Related
- 2002-12-18 MX MXPA03007156A patent/MXPA03007156A/es active IP Right Grant
- 2002-12-18 CZ CZ20031970A patent/CZ20031970A3/cs unknown
- 2002-12-18 RU RU2003125371/15A patent/RU2323717C2/ru active
- 2002-12-18 CN CNB028084683A patent/CN100341491C/zh not_active Expired - Lifetime
2003
- 2003-07-01 IS IS6863A patent/IS6863A/is unknown
- 2003-08-18 NO NO20033653A patent/NO320358B1/no not_active IP Right Cessation
2004
- 2004-09-16 US US10/942,407 patent/US7815938B2/en not_active Expired - Lifetime
2008
- 2008-08-28 AU AU2008207594A patent/AU2008207594A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE60202662T2 (de)	2006-01-05
US20040030033A1 (en)	2004-02-12
HUP0303886A3 (en)	2005-05-30
NO320358B1 (no)	2005-11-28
DE60202662D1 (de)	2005-02-24
KR20040065989A (ko)	2004-07-23
RU2003125371A (ru)	2005-02-10
CN100341491C (zh)	2007-10-10
ATE287259T1 (de)	2005-02-15
AU2002361447B2 (en)	2008-05-29
HK1058312A1 (en)	2004-05-14
IL156998A0 (en)	2004-02-08
EP1355633B1 (en)	2005-01-19
BR0206441A (pt)	2003-12-30
CN1503663A (zh)	2004-06-09
IS6863A (is)	2003-07-01
EP1355633A1 (en)	2003-10-29
US7815938B2 (en)	2010-10-19
US6827947B2 (en)	2004-12-07
SK9132003A3 (en)	2004-02-03
DK1355633T3 (da)	2005-04-04
JP2005514386A (ja)	2005-05-19
SI1355633T1 (en)	2005-06-30
AU2008207594A1 (en)	2008-09-18
CA2435729A1 (en)	2003-06-26
NO20033653D0 (no)	2003-08-18
PT1355633E (pt)	2005-05-31
PL362378A1 (en)	2004-10-18
DE20220902U1 (de)	2004-06-09
HUP0303886A2 (hu)	2004-05-28
AU2002361447A1 (en)	2003-06-30
WO2003051340A1 (en)	2003-06-26
ES2233876T3 (es)	2005-06-16
EP1477163A1 (en)	2004-11-17
US20050089574A1 (en)	2005-04-28
CA2435729C (en)	2005-12-13
RU2323717C2 (ru)	2008-05-10
CZ20031970A3 (cs)	2003-10-15
MXPA03007156A (es)	2003-11-18
NZ526926A (en)	2006-02-24

Publication	Publication Date	Title
NO20033653L (no)	2003-10-10	Ny filmcoating
NZ526792A (en)	2004-12-24	Film coating composition for controlled release from pharmaceutical formulations
DK0868912T3 (da)	2003-01-06	Anvendelse af redispergerbare polymerpulvere eller polymergranulater til coating af farmaceutiske eller agrokemiske applikationsformer
DE60204158D1 (de)	2005-06-16	Beschichtungen mit immobilisierten partikeln sowie verwendungen derselben
CY1112517T1 (el)	2015-12-09	Φαρμακοτεχνικες μορφες τροποποιημενης αποδεσμευσης μιας τουλαχιστον μορφης τραμαδολης
BRPI0509659A8 (pt)	2018-02-06	Processo para a preparação de uma composição de polímero de dispersão aquosa
ATE241341T1 (de)	2003-06-15	Stabilisierte pharmazeutische zusammensetzung
DK2332523T4 (da)	2022-02-21	Ensartede film til hurtigtopløsende doseringsform indeholdende smagsmaskerende præparater
KR910011242A (ko)	1991-08-07	서방성 약학제제 및 그의 제조방법
WO2005063231A3 (en)	2006-05-18	Formulation containing an eicosapentaenoic acid or an ester thereof and a triterpene or esther thereof
EP1269994A3 (en)	2003-02-12	Pharmaceutical compositions comprising drug and concentration-enhancing polymers
WO2005048923A3 (en)	2006-08-17	Extended release venlafaxine formulation
DK0549331T3 (da)	1997-09-15	Tilførselsanordning til styret lægemiddelafgivelse
DE50208048D1 (de)	2006-10-19	Beschichtungsmittel für verschmutzungsresistente Beschichtungen
ATE423179T1 (de)	2009-03-15	Amphiphile copolymerzusammensetzungen
WO2007041367A3 (en)	2007-11-29	Oral composition containing a salivation inducing agent
BR0311773A (pt)	2006-06-13	composição de revestimento tendo partìculas diluentes de cloreto de polivinila
TW200615692A (en)	2006-05-16	Radiation sensitive composition and method for the preparation of the same
EP1435370A4 (en)	2005-04-27	COMPOSITION OF COATING MATERIAL
WO2004048425A3 (en)	2004-08-19	Polyamphoteric superabsorbent copolymers
ATE444739T1 (de)	2009-10-15	Polymerzusammensetzung sowie diese enthaltende darreichungsformen
SE0202353D0 (sv)	2002-08-01	New film coating
CO4940371A1 (es)	2000-07-24	Producto cosmetico removedor de tapones queratotonicos de la piel
SE0104327D0 (sv)	2001-12-19	New film coating
ATE392644T1 (de)	2008-05-15	Alpha-(1' -hydroxyalkyl)acrylate enthaltende beschichtungsmassen

Legal Events

Date	Code	Title	Description
2010-07-19	MM1K	Lapsed by not paying the annual fees